|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
US5124061A
(en)
|
1991-04-01 |
1992-06-23 |
Geary Sr Robert J |
Systemic plant cryoprotection with choline salts
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
AU7685894A
(en)
|
1993-09-07 |
1995-03-27 |
Amylin Pharmaceuticals, Inc. |
Methods for regulating gastrointestinal motility
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
CA2202520C
(en)
|
1994-10-13 |
2000-09-05 |
Masanobu Takeuchi |
Lyophilized pharmaceutical preparations capable of providing aqueous drug composition having property of reversible thermosetting gelation
|
|
EP1886677A1
(en)
|
1996-07-26 |
2008-02-13 |
Susan P. Perrine |
Use of an inducing agent for the treatment of blood, viral and cellular disorders
|
|
US6365185B1
(en)
|
1998-03-26 |
2002-04-02 |
University Of Cincinnati |
Self-destructing, controlled release peroral drug delivery system
|
|
US7654986B2
(en)
|
2002-07-03 |
2010-02-02 |
Novo Nordisk A/S |
Needle mounting system and a method for mounting a needle assembly
|
|
US20040110755A1
(en)
|
2002-08-13 |
2004-06-10 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Combination therapy with p38 MAP kinase inhibitors and their pharmaceutical compositions
|
|
GB0228571D0
(en)
|
2002-12-06 |
2003-01-15 |
Novartis Ag |
Organic compounds
|
|
GB0312309D0
(en)
|
2003-05-29 |
2003-07-02 |
Gaslini Children S Hospital G |
Targeted liposome
|
|
CN100522998C
(zh)
|
2003-10-01 |
2009-08-05 |
协和发酵麒麟株式会社 |
抗体的稳定化方法和被稳定的溶液状抗体制剂
|
|
TR201906789T4
(tr)
|
2003-11-20 |
2019-05-21 |
Novo Nordisk As |
Üretim ve enjeksiyon cihazlarında kullanım için en uygun olan propilen glikol ihtiva eden peptit formülasyonları.
|
|
US7686786B2
(en)
|
2004-10-21 |
2010-03-30 |
Novo Nordiks A/S |
Dial-down mechanism for wind-up pen
|
|
DK1819382T4
(da)
|
2004-10-21 |
2024-11-04 |
Novo Nordisk As |
Injektionsanordning med torsionsfjeder og drejeligt display
|
|
CN100526289C
(zh)
|
2004-12-06 |
2009-08-12 |
河北师范大学 |
无毒离子液体、制备方法及其应用
|
|
ES2633917T3
(es)
|
2005-01-21 |
2017-09-26 |
Novo Nordisk A/S |
Dispositivo de inyección automático con un mecanismo de liberación superior
|
|
PL1877119T3
(pl)
|
2005-01-25 |
2019-03-29 |
Novo Nordisk A/S |
Urządzenie do wstrzykiwania z mechanizmem zwrotnym informującym o końcu dawki
|
|
MX2007010539A
(es)
|
2005-02-28 |
2007-10-17 |
Unilever Nv |
Composicion cosmetica mejorada.
|
|
TWI372629B
(en)
|
2005-03-18 |
2012-09-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
WO2007017053A1
(en)
|
2005-07-27 |
2007-02-15 |
Novo Nordisk A/S |
Syringe device with a dose limiting mechanism and an additional safety mechanism
|
|
CA2658673A1
(en)
|
2005-07-27 |
2008-02-01 |
Gerald J. Prud'homme |
Composition and method for prevention and treatment of type i and type ii diabetes
|
|
ATE499962T1
(de)
|
2005-07-27 |
2011-03-15 |
Novo Nordisk As |
Dosismechanismus für ein injektionsgerät zur begrenzung einer dosiseinstellung entsprechend der verbleibenden arzneimenge
|
|
CA2867194C
(en)
|
2005-10-07 |
2016-10-04 |
The University Of Alabama |
Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients
|
|
JP5252435B2
(ja)
|
2006-03-15 |
2013-07-31 |
ノボ・ノルデイスク・エー／エス |
アミリン誘導体
|
|
US9132239B2
(en)
|
2008-10-24 |
2015-09-15 |
Novo Nordisk A/S |
Dial-down mechanism for wind-up pen
|
|
WO2010118384A2
(en)
|
2009-04-10 |
2010-10-14 |
Amylin Pharmaceuticals, Inc. |
Amylin agonist compounds for estrogen-deficient mammals
|
|
EP2512518A1
(en)
|
2009-12-16 |
2012-10-24 |
Novo Nordisk A/S |
Glp-1 receptor agonist compounds with a modified n-terminus
|
|
CA2786953A1
(en)
|
2010-01-12 |
2011-07-21 |
Florian Anders Foeger |
Pharmaceutical compositions for oral administration of insulin peptides
|
|
DE102010007562A1
(de)
|
2010-02-10 |
2011-08-11 |
sterna biologicals GmbH & Co KG, 35043 |
Dermatologische, pharmazeutische Zusammensetzung geeignet für Oligonukleotide
|
|
CA3070513C
(en)
|
2010-05-05 |
2023-01-03 |
Boehringer Ingelheim International Gmbh |
A dpp-4 inhibitor for use in treatment of skin-alterations or necrosis
|
|
WO2012051567A2
(en)
|
2010-10-15 |
2012-04-19 |
The Trustees Of Columbia University In The City Of New York |
Obesity-related genes and their proteins and uses thereof
|
|
MX377589B
(es)
|
2010-12-16 |
2025-03-10 |
Novo Nordisk As |
Composiciones sólidas que comprenden agonista de glp-1 y sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico.
|
|
US20140045754A1
(en)
|
2011-01-19 |
2014-02-13 |
Joern Drustrup |
Glp-1 compositions
|
|
JP2014521594A
(ja)
|
2011-05-25 |
2014-08-28 |
アミリン・ファーマシューティカルズ，リミテッド・ライアビリティ・カンパニー |
長持続期間デュアルホルモンコンジュゲート
|
|
CA2837104A1
(en)
|
2011-05-25 |
2012-11-29 |
Amylin Pharmaceuticals, Llc |
Amylin peptides and derivatives and uses thereof
|
|
WO2012168431A2
(en)
|
2011-06-10 |
2012-12-13 |
Novo Nordisk A/S |
Polypeptides
|
|
ES2660118T3
(es)
|
2011-10-05 |
2018-03-20 |
Jeffrey M. Golini |
Composición de colina
|
|
CN104203266B
(zh)
|
2012-03-22 |
2017-12-26 |
诺和诺德股份有限公司 |
Glp‑1肽组合物及其制备
|
|
HRP20251088T1
(hr)
|
2012-07-01 |
2025-11-07 |
Novo Nordisk A/S |
Upotreba dugodjelujućih peptida glp‑1
|
|
JP6559394B2
(ja)
|
2012-12-05 |
2019-08-14 |
ミヨシ油脂株式会社 |
親水性室温イオン液体とその用途
|
|
AU2012397212B2
(en)
|
2012-12-20 |
2015-11-12 |
Colgate-Palmolive Company |
Oral care composition containing ionic liquids
|
|
JP6672140B2
(ja)
|
2013-05-02 |
2020-03-25 |
ノヴォ ノルディスク アー／エス |
Ｇｌｐ−１化合物の経口投薬
|
|
IL312865B2
(en)
|
2013-09-11 |
2025-06-01 |
Eagle Biologics Inc |
Liquid protein formulations containing viscosity-lowering agents
|
|
US10449254B2
(en)
|
2013-11-03 |
2019-10-22 |
The Regents Of The University Of California |
Ionic liquids for transdermal drug delivery
|
|
EP3050557A1
(en)
|
2014-05-23 |
2016-08-03 |
Ares Trading S.A. |
Liquid pharmaceutical composition
|
|
CN106687474A
(zh)
|
2014-09-04 |
2017-05-17 |
诺和诺德股份有限公司 |
新型胰淀素和降钙素受体激动剂
|
|
EP3200804A4
(en)
|
2014-10-01 |
2018-04-18 |
Eagle Biologics, Inc. |
Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
|
|
AU2015249035A1
(en)
|
2014-11-14 |
2016-06-02 |
Zoran Ivanov |
Compositions and methods for treatment or prophylaxis of a liver condition
|
|
EP3359181A1
(en)
|
2015-10-07 |
2018-08-15 |
Cyprumed GmbH |
Pharmaceutical formulations for the oral delivery of peptide drugs
|
|
KR101764018B1
(ko)
|
2015-11-04 |
2017-08-16 |
포항공과대학교 산학협력단 |
고성능 리튬-황 전지 유-무기 복합 전해질
|
|
KR20170052278A
(ko)
|
2015-11-04 |
2017-05-12 |
주식회사 엘지생활건강 |
바이오필름 제거용 구강 조성물
|
|
WO2017164627A2
(ko)
|
2016-03-21 |
2017-09-28 |
주식회사 엘지생활건강 |
바이오필름 억제 또는 제거용 조성물
|
|
KR101978828B1
(ko)
|
2016-03-21 |
2019-05-15 |
주식회사 엘지생활건강 |
바이오필름 제거용 조성물
|
|
JP7179354B2
(ja)
|
2016-08-29 |
2022-11-29 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
皮膚処置のためのイオン種に基づく局所処方物
|
|
US10463733B1
(en)
|
2016-10-04 |
2019-11-05 |
United States of America as represented by the Secetary of the Air Force |
Ultra-stable protein ionic liquids
|
|
US10293080B2
(en)
|
2016-10-05 |
2019-05-21 |
The Arizona Board Of Regents On Behalf Of Northern Arizona University |
Ionic liquids that sterilize and prevent biofilm formation in skin wound healing devices
|
|
WO2018065634A1
(en)
|
2016-10-07 |
2018-04-12 |
Cyprumed Gmbh |
Pharmaceutical compositions for the nasal delivery of peptide or protein drugs
|
|
CN106420610B
(zh)
|
2016-10-21 |
2019-06-11 |
昆明理工大学 |
一种离子液体微乳及其应用
|
|
US11654112B2
(en)
|
2016-11-22 |
2023-05-23 |
Elektrofi, Inc. |
Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
|
|
US11608357B2
(en)
|
2018-08-28 |
2023-03-21 |
Arecor Limited |
Stabilized antibody protein solutions
|
|
US11213497B2
(en)
|
2017-06-01 |
2022-01-04 |
Arizona Board Of Regents On Behalf Of Northern Arizona University |
Antibiofilm formulations
|
|
HRP20240485T1
(hr)
|
2017-08-24 |
2024-07-05 |
Novo Nordisk A/S |
Pripravci glp-1 i njihova upotreba
|
|
CN111918644A
(zh)
|
2017-11-17 |
2020-11-10 |
哈佛大学校长及研究员协会 |
用于内部递送的离子液体
|
|
AR113996A1
(es)
|
2017-12-22 |
2020-07-08 |
Intervet Int Bv |
Vacunas líquidas de virus envueltos vivos
|
|
EP3768240A4
(en)
|
2018-03-19 |
2021-12-22 |
Cage Bio Inc. |
COMPOSITIONS OF IONIC LIQUID FOR THE TREATMENT OF ROSACEA
|
|
RS63523B1
(sr)
|
2018-04-05 |
2022-09-30 |
Sun Pharmaceutical Ind Ltd |
Novi glp-1 analozi
|
|
EP3773475A1
(en)
|
2018-04-06 |
2021-02-17 |
Cyprumed GmbH |
Pharmaceutical compositions for the transmucosal delivery of therapeutic peptides and proteins
|
|
EP3781192A1
(en)
|
2018-04-16 |
2021-02-24 |
Merck Patent GmbH |
Additives for protein formulations to improve thermal stability
|
|
US11464738B2
(en)
|
2018-05-11 |
2022-10-11 |
Wisconsin Alumni Research Foundation |
Ionic liquid-based nanoemulsion formulation for the efficient delivery of hydrophilic and hydrophobic therapeutic agents
|
|
WO2020004368A1
(ja)
|
2018-06-25 |
2020-01-02 |
Ｊｃｒファーマ株式会社 |
蛋白質含有水性液剤
|
|
CN109464661B
(zh)
|
2018-12-14 |
2022-05-10 |
中国科学院过程工程研究所 |
一种疫苗抗原组合物及其制备方法
|
|
EP3930757A1
(en)
|
2019-03-01 |
2022-01-05 |
President And Fellows Of Harvard College |
Methods and compositions for protein delivery
|
|
US20220257767A1
(en)
|
2019-04-03 |
2022-08-18 |
President And Fellows Of Harvard College |
Ionic liquids for drug delivery
|
|
CN115348858A
(zh)
|
2019-11-08 |
2022-11-15 |
凯奇生物公司 |
使用离子液体的托法替尼表面递送
|
|
WO2021102084A1
(en)
|
2019-11-22 |
2021-05-27 |
President And Fellows Of Harvard College |
Ionic liquids for drug delivery
|
|
PE20230819A1
(es)
|
2020-02-18 |
2023-05-19 |
Novo Nordisk As |
Composiciones y usos de glp-1
|
|
CN115884959A
(zh)
|
2020-04-22 |
2023-03-31 |
耶路撒冷希伯来大学伊森姆研究发展有限公司 |
生物活性的苯酚盐离子络合物
|
|
CN115996751A
(zh)
|
2020-04-28 |
2023-04-21 |
哈佛大学校长及研究员协会 |
与离子液体佐剂有关的方法和组合物
|
|
US11684594B2
(en)
|
2020-05-12 |
2023-06-27 |
President And Fellows Of Harvard College |
Antifungal prophylaxis for cornea
|
|
CN111588846A
(zh)
|
2020-05-21 |
2020-08-28 |
中国科学院过程工程研究所 |
一种疫苗组合物及其制备方法和应用
|
|
AU2021325965A1
(en)
|
2020-08-14 |
2023-03-16 |
Mayo Foundation For Medical Education And Research |
Methods and materials for tissue ablation
|
|
AU2021336289A1
(en)
|
2020-09-01 |
2023-05-04 |
I2O Therapeutics, Inc. |
Ionic liquid formulations for treating diabetes
|
|
WO2022049310A1
(en)
|
2020-09-07 |
2022-03-10 |
Cyprumed Gmbh |
Improved pharmaceutical formulations of glp-1 receptor agonists
|
|
JP2024518169A
(ja)
|
2021-05-05 |
2024-04-25 |
アイ２オー セラピューティクス，インク． |
炎症性疾患および自己免疫疾患を処置するためのイオン性液体製剤
|
|
WO2022256291A1
(en)
|
2021-06-01 |
2022-12-08 |
President And Fellows Of Harvard College |
Hydrogel devices for drug delivery to the ear
|
|
WO2022254209A1
(en)
|
2021-06-04 |
2022-12-08 |
Imperial College Innovations Limited |
Stable composition
|
|
WO2022265880A1
(en)
|
2021-06-16 |
2022-12-22 |
President And Fellows Of Harvard College |
Improved methods and compositions for drug delivery relating to ionic liquids
|
|
CN118382429A
(zh)
|
2021-10-08 |
2024-07-23 |
哈佛大学校长及研究员协会 |
用于药物递送的离子液体
|
|
EP4429704A4
(en)
|
2021-11-10 |
2025-11-05 |
I2O Therapeutics Inc |
IONIC LIQUID COMPOSITIONS
|
|
WO2023110833A1
(en)
|
2021-12-13 |
2023-06-22 |
Novo Nordisk A/S |
Pharmaceutical formulations comprising a cyclodextrin
|
|
EP4486366A1
(en)
|
2022-03-03 |
2025-01-08 |
Cyprumed GmbH |
Improved oral pharmaceutical formulations of therapeutic peptides and proteins
|
|
WO2023187067A1
(en)
|
2022-03-30 |
2023-10-05 |
Novo Nordisk A/S |
Formulation method
|
|
JP2025517031A
(ja)
|
2022-05-27 |
2025-05-30 |
ハンチョウ サイウィンド バイオサイエンスィズ カンパニー リミテッド |
ヒトアミリン類似体、その誘導体およびその使用
|
|
US20260108600A1
(en)
|
2022-10-07 |
2026-04-23 |
President And Fellows Of Harvard College |
Methods and compositions relating to improved ionic liquid adjuvants
|